Practice patterns of post-ERCP pancreatitis prophylaxis techniques in the United States: a survey of advanced endoscopists
The American Society for Gastrointestinal Endoscopy (ASGE) recommends prophylactic pancreatic duct stent placement (PPS) and rectal nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce the incidence and severity of post-ERCP pancreatitis (PEP) in high-risk individuals and suggests that rectal indomethacin may decrease the risk and severity of PEP in average-risk individuals. The European Society for Gastrointestinal Endoscopy (ESGE) recommends rectal indomethacin for all patients undergoing ERCP.
Source: Gastrointestinal Endoscopy - Category: Gastroenterology Authors: Patrick Avila, Ian Holmes, Abdul Kouanda, Mustafa Arain, Sun-Chuan Dai Source Type: research
More News: Endoscopy | ERCP | Gastroenterology | Indomethacin | Pancreas | Pancreatitis | USA Health